Xconomy San Diego

Aragon Pharmaceuticals Inc Garners $8,000,000 Series A Financing

  • Feed Type
  • Date
    5/21/2009
  • Company Name
    Aragon Pharmaceuticals Inc
  • Mailing Address
    6755 Mira Mesa Blvd San Diego, CA 92121
  • Company Description
    Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers.
  • Website
    http://www.aragonpharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company said the funding will be used to develop new small molecule drugs for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.
  • M&A Terms
  • Venture Investor
    The Column Group
  • Venture Investor
    OrbiMed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.